Related Experiment Video

Updated: Jun 26, 2026

Design to Implementation Study for Development and Patient Validation of Paper-Based Toehold Switch Diagnostics
10:42

Design to Implementation Study for Development and Patient Validation of Paper-Based Toehold Switch Diagnostics

Published on: June 17, 2022

Clinical investigation in pediatrics: challenges and opportunities in Toronto, Canada

Shinya Ito1

  • 1Clinical Pharmacology and Toxicology, Hospital for Sick Children, University of Toronto, Ontario, Canada. shinya.ito@sickkids.ca

Paediatric Drugs
|January 9, 2009
PubMed

Insights

Pediatric clinical investigation faces challenges due to limited resources and patient numbers. Opportunities lie in research infrastructure evolution, team amalgamation, and facility centralization for better drug research in children.

Area of Science:

  • Pediatric clinical investigation
  • Biomedical research infrastructure
  • Translational research

Background:

  • Clinical investigation in children presents unique challenges.
  • The Hospital for Sick Children in Toronto, Canada, faces these hurdles.
  • Resource intensity is increasing for both preclinical and clinical studies.

Purpose of the Study:

  • To discuss challenges and opportunities in pediatric clinical investigation.
  • To examine program structure, shared platforms, and infrastructure.
  • To identify trends and propose solutions for advancing pediatric research.

Main Methods:

  • Discussion of program structure within the Research Institute.
  • Analysis of the Toronto Centre for Phenogenomics as a preclinical platform.
  • Evaluation of evolving clinical research infrastructure.

Main Results:

  • Trends include research team amalgamation and facility centralization.
  • Pediatric research is uniquely challenged by fewer human resources and patients.
  • Organizational changes are occurring at local and national levels.

Conclusions:

  • Advancing pediatric drug research requires broader international collaboration.
  • Functional amalgamation and infrastructure expansion are key opportunities.
  • Addressing resource and patient number limitations is critical for pediatric clinical investigation.

More Related Videos

Testing Sensory and Multisensory Function in Children with Autism Spectrum Disorder09:13

Testing Sensory and Multisensory Function in Children with Autism Spectrum Disorder

Published on: April 22, 2015

Related Concept Videos

Clinical Trials01:16

Clinical Trials

Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Clinical Trials: Overview01:11

Clinical Trials: Overview

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Investigation of Disease Outbreaks01:23

Investigation of Disease Outbreaks

Multistate foodborne outbreaks pose significant public health risks and require meticulous investigation to identify sources and implement control measures. The Centers for Disease Control and Prevention (CDC) utilizes a dynamic seven-step process for these investigations, integrating data from laboratories, interviews, and environmental assessments to protect public health.Outbreak Detection: The detection of multistate outbreaks typically begins with PulseNet, the CDC's national laboratory...